Trial intelligence / Profile preview

Effect of Adding Sina Curcumin to Sertraline in Treatment of Depression

IRCT20101130005280N26Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of sertraline in major depressive disorder (MDD), sponsored by Mashhad University of Medical Sciences. Started Jan 2017; status: completed.

02

Drugs

sertraline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on IRCT20101130005280N26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20101130005280N26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call